VTRS.NASDAQViatris INC

Form 4: Viatris Inc. Executive Corinne Le Goff Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Chief Commercial Officer Corinne Le Goff reports the vesting and settlement of restricted stock units and dividend equivalent units, along with associated tax withholding.

Summary

  • On March 4, 2025, Corinne Le Goff, Chief Commercial Officer of Viatris Inc., reported transactions involving common stock and derivative securities.
  • 36,721 restricted stock units (RSUs) vested, resulting in the acquisition of 36,721 shares of common stock.
  • 16,276 shares were withheld to cover tax liabilities related to the RSU vesting at a price of $9.37 per share.
  • 1,173 dividend equivalent units (DEUs) vested, leading to the acquisition of 1,173 shares of common stock.
  • 521 shares were withheld to cover tax liabilities related to the DEU vesting at a price of $9.37 per share.
  • Following these transactions, Le Goff directly owns 21,097 shares of Viatris Inc. common stock and 73,441 restricted stock units.
  • She also owns 2,344 dividend equivalent units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investor confidence and regulatory oversight.

Comparison to Industry Standards

  • Executive compensation packages often include restricted stock units (RSUs) as a way to align management's interests with those of shareholders.
  • The vesting schedules for RSUs, such as the one described in this filing, are typical in the industry, with vesting occurring over several years.
  • Tax withholding practices related to RSU vesting are also standard, ensuring compliance with tax regulations.
  • Companies like Teva Pharmaceuticals, Novartis, and Pfizer also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

  • The transactions reported in this filing may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
  • The vesting of RSUs and DEUs is part of the executive's compensation package, which is of interest to shareholders.

Key Dates

DateDescription
April 18, 2024Date of grant for the restricted stock units (RSUs).
March 4, 2025Date of the reported transactions, including vesting of RSUs and DEUs.
March 4, 2026Date when 36,720 RSUs will vest.
March 4, 2027Date when 36,721 RSUs will vest.
March 5, 2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.